Ubicare, 3Q Sales 26.7 Billion KRW and Operating Profit 2.9 Billion KRW

UbieCare CI (Photo by UbieCare)

[Asia Economy Reporter Chunhee Lee] Digital healthcare solution company Ubicare announced on the 4th that its consolidated financial statement-based provisional operating results for the third quarter showed sales of 26.724 billion KRW. This represents a 3.2% increase compared to the same period last year.

Operating profit was 2.859 billion KRW, and net profit was 2.528 billion KRW, showing decreases of 33.3% and 39.5% respectively compared to the same period last year. However, net profit successfully turned positive from a deficit of 12 million KRW in the second quarter of this year. .

By business segment, the hospital/clinic/pharmacy EMR (Electronic Medical Records) division recorded sales of 13.9 billion KRW, and the medical device distribution division recorded sales of 10.3 billion KRW, growing by 5.6% and 2.3% respectively. In particular, in the EMR-related business, the subsidiary Hecton Project's sales of EMR for Korean medicine and nursing hospitals continued steady growth, and the increase in EMR-linked additional businesses supported the performance. On the other hand, sales in the pharmaceutical and data business division slowed as more pharmaceutical companies attempted to reduce marketing expenses due to COVID-19.

An Ubicare official stated, “Despite the difficult situation caused by COVID-19, we achieved meaningful results in key business sectors,” and added, “Operating profit decreased due to the impact of temporary cost increases.”

This content was produced with the assistance of AI translation services.